At Biogen Idec, we focus our efforts on therapeutic areas where there is a high unmet medical need and on programs that offer the greatest potential to make a real difference in the lives of patients.
Our expertise and commitment have produced the industry’s most robust MS franchise, helping to manage the disease from its earliest signs through its later stages. Our vision is to extend this leadership to transform the standard of care for hemophilia, to excel in discovery science and continue innovating at the intersection of science, medicine and economics to transform drug development.
But our commitment to improving patients’ lives goes beyond the treatments we develop; we also work hard to support patients and their caregivers with a range of best-in-class services. For example, we’ve created a number of programs under the MS ActiveSource® umbrella to help with the informational, emotional and logistical considerations that are part of living with MS. We also help patients and their families address the financial impact of treatment through our ActiveAccess program.